Overview
- Administrative Law Judge Monica Bhattacharyya issued an initial determination finding no direct or induced infringement by the current blood‑oxygen implementation.
- The recommendation now goes to the full International Trade Commission, which can affirm, modify, or reverse the ruling.
- The Federal Circuit separately affirmed the ITC’s 2023 exclusion order, so Apple cannot restore the original on‑watch version of the feature.
- Apple’s workaround shifts pulse‑oximetry processing and results display to a paired iPhone, a design U.S. Customs cleared in August 2025 that Masimo is challenging in court.
- The wider dispute continues across multiple venues, including Masimo’s $634 million jury award in November 2025 and its pending acquisition by Danaher, while Apple says it is evaluating further review options.